No abstract available
Keywords:
Alendronate; Denosumab; Metatarsal bones; Osteoporosis.
MeSH terms
-
Aged
-
Bone Density Conservation Agents* / adverse effects
-
Denosumab* / adverse effects
-
East Asian People
-
Female
-
Fractures, Bone
-
Humans
-
Metatarsal Bones* / injuries
-
Osteoporosis, Postmenopausal* / drug therapy
Substances
-
Bone Density Conservation Agents
-
Denosumab